HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial Cancer
Modern Pathology · 2023-11 · 36 (11) · 100299
DOI: 10.1016/j.modpat.2023.100299 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Pathology, 2023-11. Verfasst von Sherry Shen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Carcinoma, Breast Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
- Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
- Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
- Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
- Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, New York.
- Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: chuim1@mskcc.org.
Förderung
- NCI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Shen, S., Ma, W., Brown, D., Da Cruz Paula, A., Zhou, Q., Iaosonos, A., Tessier-Cloutier, B., Ross, D. S., Troso-Sandoval, T., Reis-Filho, J. S., Abu-Rustum, N., Zhang, Y., Ellenson, L. H., Weigelt, B., Makker, V., & Chui, M. H. (2023). HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial Cancer. Modern Pathology, 36(11), 100299. https://doi.org/10.1016/j.modpat.2023.100299
Vancouver
Shen S, Ma W, Brown D, Da Cruz Paula A, Zhou Q, Iaosonos A, et al. HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial Cancer. Modern Pathology. 2023;36(11):100299. doi:10.1016/j.modpat.2023.100299
BibTeX
@article{Shen2023,
author = {Shen, Sherry and Ma, Weining and Brown, David and Da Cruz Paula, Arnaud and Zhou, Qin and Iaosonos, Alexia and Tessier-Cloutier, Basile and Ross, Dara S and Troso-Sandoval, Tiffany and Reis-Filho, Jorge S and Abu-Rustum, Nadeem and Zhang, Yanming and Ellenson, Lora H and Weigelt, Britta and Makker, Vicky and Chui, M Herman},
title = {HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial Cancer},
journal = {Modern Pathology},
year = {2023},
volume = {36},
number = {11},
pages = {100299},
doi = {10.1016/j.modpat.2023.100299}
}
EUVIMED